Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSXV/DB stock hub

TSXV/DB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/DBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

72.1M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/DB

In the news

Latest news · TSXV/DB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.4

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-4.6

P25 -121.5P50 -40.9P75 0.5

ROIC-0.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/DB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

CAD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 108.8M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA2434371001
Last refreshed	2026-05-10
Market cap	CAD 72.1M
Price	CAD 0.13
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/DB
Website	https://www.decibelcc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.05%
EV Earnings	-37.21x
EV/EBITDA	17.47x
EV/FCF	19.64x
EV/Sales	0.97x
FCF yield	7.68%
Forward P/E	9.38x
P/B ratio	1.16x
P/S ratio	0.64x
PEG ratio	9.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.17%
EBITDA Margin	3.11%
FCF margin	4.91%
Gross margin	36.75%
Gross Profit	CAD 41.4M
Gross Profit Growth	10.24%
Gross Profit Growth Q	18.37%
Gross Profit Growth3 Y	16.16%
Gross Profit Growth5 Y	28.6%
Net Income	CAD -2.9M
Net Income Growth Years	0%
Pretax Margin	-2.59%
Profit Margin	-2.59%
ROA	-0.08
Roa5y	1.17
ROCE	-0.2
ROE	-4.6
Roe5y	2.17
ROIC	-0.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	92.39%
Cagr5y	-8.97%
EPS Growth Years	0
FCF Growth	70.78%
FCF Growth3 Y	3.53%
OCF Growth	87.39%
OCF Growth Q	1,636.45%
OCF Growth3 Y	-3.34%
Revenue Growth	21.81x
Revenue Growth Q	13.49x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	12.43x
Revenue Growth5 Y	30.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.77
Assets	CAD 141.6M
Cash	CAD 7.5M
Current Assets	CAD 60.9M
Current Liabilities	CAD 45.4M
Debt	CAD 44.2M
Debt EBITDA	CAD 7.09
Debt Equity	CAD 0.71
Debt FCF	CAD 7.97
Equity	CAD 62.4M
Interest Coverage	-0.07
Liabilities	CAD 79.2M
Long Term Assets	CAD 80.7M
Long Term Liabilities	CAD 33.8M
Net Cash	CAD -36.7M
Net Cash By Market Cap	CAD -50.83
Net Debt EBITDA	CAD 10.46
Net Debt Equity	CAD 0.59
Net Debt FCF	CAD 6.62
Tangible Book Value	CAD 62M
Tangible Book Value Per Share	CAD 0.11
WACC	6.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Inventory Turnover	1.96
Net Working Capital	CAD 19.4M
Quick ratio	0.58
Working Capital	CAD 15.5M
Working Capital Turnover	CAD 7.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-35.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	92.31%
200-day SMA	0.12
50-day SMA	0.12
50-day SMA vs 200-day SMA	50over200
5Y total return	-37.5%
All Time High	0.37
All Time High Change	-65.75%
All Time High Date	2021-07-29
All Time Low	0.04
All Time Low Change	257.14%
All Time Low Date	2024-08-14
ATR	0.01
Beta	0.62
Beta1y	0.79
Beta2y	0.3
Ch YTD	13.64
High	0.13
High52	0.15
High52 Date	2025-10-07
High52ch	-16.67%
Low	0.13
Low52	0.06
Low52 Date	2025-06-05
Low52ch	108.33%
Ma50ch	1.96%
Price vs 200-day SMA	6.47%
RSI	49.47
RSI Monthly	55.57
RSI Weekly	56.26
Sharpe ratio	1.08x
Sortino ratio	1.82
Total Return	-35.43%
Tr YTD	13.64
Tr1m	-3.85%
Tr1w	4.17%
Tr3m	38.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -192,000
Operating margin	-0.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	429,276,473%
Net Borrowing	-4,977,000
Shares Insiders	5.76%
Shares Out	577,043,267
Shares Qo Q	-1.11%
Shares Yo Y	35.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 4.2M
Average Volume	290,405.25x
Bv Per Share	0.11
CAPEX	CAD -1.9M
Ch1m	-3.85
Ch1w	4.17
Ch1y	92.31
Ch3m	38.89
Ch5y	-37.5
Ch6m	-3.85
Change	0%
Change From Open	0
Close	0.13
Days Gap	0
Depreciation Amortization	3,697,000
Dollar Volume	27,043.6
Earnings Date	2026-04-16
EBIT	CAD -192,000
EBITDA	CAD 3.5M
EPS	CAD -0.01
F Score	5
FCF	CAD 5.5M
FCF EV Yield	5.09x
FCF Per Share	CAD 0.01
Financing CF	-4,977,000
Fiscal Year End	December
Investing CF	-1,984,000
Is Primary Listing	1
Last Earnings Date	2026-04-16
Last Report Date	2025-12-31
Ma150	0.12
Ma150ch	7.11%
Ma20	0.13
Ma20ch	-2.11%
Net CF	497,000
Open	0.13
P FCF Ratio	13.02
P OCF Ratio	9.67
Position In Range	0
Ppne	76,357,000
Price Date	2026-05-08
Price EBITDA	CAD 20.58
Ptbv Ratio	1.16
Relative Volume	0.73x
Revenue	112,722,000x
SBC By Revenue	1.16x
Share Based Comp	1,303,000
Tr6m	-3.85%
Volume	216,349
Z Score	1.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/DB pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/DB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/DB?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+5.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+35.4%

Negative means the company is buying back shares.

Technical

TSXV/DB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.5

Neutral momentum band

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/DB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/DB stock rating?

tsxv/DB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/DB analysis?

The full report lives at /stocks/tsxv/DB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/DB?

The latest report frames tsxv/DB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/DB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.